Lumida
/APGE
⌘K
Apogee Therapeutics Inc

Apogee Therapeutics Inc

APGE
$135.07USD-0.01%-0.01 today

MARKET CAP

10.2B

P/E (TTM)

FWD P/E

DAY RANGE

$135 – $135

52W RANGE

$35
$135

AI Summary

Stalk
StalkMedium

APGE remains in a Stage 2 parabolic advance with strong volume, currently extended above rising EMAs and overbought. Under a speculative strategy, defer new exposure until a shallow pullback into the 9/20-EMA support zone shows reclaim and acceptance.

  • AbbVie acquisition at $135.11/share to close Q3 2026 offers a ~premium to market
  • Phase 2 APEX trial showed 65.9% mid-dose patients hitting EASI-75 vs placebo
  • Q2 2026 net loss of $85.9 M and $67.3 M R&D spend strain margins
Full analysis →

Buying

12

institutions

Selling

7

institutions

New Positions

6

this quarter

Filing Period

Q1 2026

latest 13-F

13-F Holdings

InstitutionActionShares HeldValueChangeChg %Weight
BI

Blackrock, Inc.

Q2 2026

BUY5.51 M730.95 M+1.42 M+112.5%0.01%
JH

Janus Henderson Group Plc

Q1 2026

BUY4.72 M397.62 M+2.66 M+155.4%0.10%
BA

Balyasny Asset Management L.P.

Q2 2026

BUY2.17 M287.37 M+1.73 M+678.3%0.37%
MM

Millennium Management LLC

Q2 2026

BUY1.50 M199.29 M+1.41 M+2457.2%0.07%
PA

Perceptive Advisors LLC

Q2 2026

SELL1.31 M173.63 M+-1.77 M-33.0%2.61%
TR

T. Rowe Price Investment Management, Inc.

Q2 2026

SELL762.18 K101.17 M+-9.54 M-88.3%0.07%
SF

Soros Fund Management LLC

Q2 2026

BUYNEW564.50 K74.93 M+564.50 K+0.0%1.15%
WP

Woodline Partners LP

Q2 2026

SELL464.62 K61.67 M+-57.62 K+40.3%0.19%
MG

Man Group Plc

Q2 2026

BUY397.00 K52.69 M+355.19 K+1397.2%0.09%
JC

Jpmorgan Chase & Co

Q2 2026

SELL359.25 K47.89 M+-751.22 K-45.2%0.00%
PA

Polar Asset Management Partners Inc.

Q2 2026

BUYNEW322.67 K42.83 M+322.67 K+0.0%0.90%
RT

Renaissance Technologies LLC

Q2 2026

BUYNEW146.80 K19.48 M+146.80 K+0.0%0.03%
GM

Grantham, Mayo, Van Otterloo & Co. LLC

Q2 2026

BUYNEW137.40 K18.24 M+137.40 K+0.0%0.04%
CA

Citadel Advisors LLC

Q2 2026

SELL58.86 K7.81 M+-593.75 K-85.8%0.00%
PA

Point72 Asset Management, L.P.

Q2 2026

BUY54.56 K7.24 M+40.76 K+523.5%0.01%
AC

Adar1 Capital Management, LLC

Q2 2026

BUYNEW31.00 K4.11 M+31.00 K+0.0%0.19%
MC

Moore Capital Management, LP

Q2 2026

BUYNEW20.00 K2.65 M+20.00 K+0.0%0.04%
AC

Aqr Capital Management LLC

Q2 2026

SELL7.96 K1.06 M+-69.00+56.3%0.00%
RI

Rtw Investments, LP

Q2 2026

SELL0.000.00+-2.78 M-100.0%0.00%